Evidence map›Paper›PMID 24993534›Full record

ArticleJournal of the American College of Radiology : JACR2014

Improving diversity, inclusion, and representation in radiology and radiation oncology part 1: why these matter.

Johnson B Lightfoote, Julia R Fielding, Curtiland Deville, Richard B Gunderman, Gail N Morgan, Pari V Pandharipande, Andre J Duerinckx, Raymond B Wynn, Katarzyna J Macura

Abstract read
In one paragraph

Article in Journal of the American College of Radiology : JACR, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Incidence, Nature, and Consequences of Oncologists' Experiences With Sexual Harassment.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022
    Article
  13. Equality Is Not Fair: Imaging and Imagining the Road to Health Equity.Journal of the American College of Radiology : JACR · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Mentorship Initiatives in Radiation Oncology: A Scoping Review of the Literature.International journal of radiation oncology, biology, physics · 2021
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Johnson B LightfooteDepartment of Radiology, Pomona Valley Hospital Medical Center, Pomona, California. Electronic address: Lightfoote@msn.com.
Julia R FieldingDepartment of Radiology, University of North Carolina, Chapel Hill, North Carolina.
Curtiland DevilleDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
Richard B GundermanDepartments of Radiology and Philosophy, Indiana University, Bloomington, Indiana.
Gail N MorganVirginia Mason Medical Center, Seattle, Washington.
Pari V PandharipandeDepartment of Radiology, Harvard Medical School, Boston, Massachusetts.
Andre J DuerinckxDepartment of Radiology, Howard University College of Medicine, Washington, DC.
Raymond B WynnDepartment of Radiation Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Katarzyna J MacuraDepartment of Radiology, Johns Hopkins University, Baltimore, Maryland.

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI Rosalie Wollett · 1985 to 2026
$208.6M
NCI NIH HHS P30 CA006973
6 · The paper itself

Abstract

The ACR Commission for Women and General Diversity is committed to identifying barriers to a diverse physician workforce in radiology and radiation oncology (RRO), and to offering policy recommendations to overcome these barriers. In Part 1 of a 2-part position article from the commission, diversity as a concept and its dimensions of personality, character, ethnicity, biology, biography, and organization are introduced. Terms commonly used to describe diverse individuals and groups are reviewed. The history of diversity and inclusion in US society and health care are addressed. The post-Civil Rights Era evolution of diversity in medicine is delineated: Diversity 1.0, with basic awareness, nondiscrimination, and recruitment; Diversity 2.0, with appreciation of the value of diversity but inclusion as peripheral or in opposition to other goals; and Diversity 3.0, which integrates diversity and inclusion into core missions of organizations and their leadership, and leverages its potential for innovation and contribution. The current states of diversity and inclusion in RRO are reviewed in regard to gender, race, ethnicity, sexual orientation, and gender identity. The lack of representation and unchanged demographics in these fields relative to other medical specialties are explored. The business case for diversity is discussed, with examples of successful models and potential application to the health care industry in general and to RRO. The moral, ethical, and public health imperative for diversity is also highlighted.

Indexed as

Cultural DiversityMinority GroupsPhysiciansPrejudiceRadiation OncologyUnited StatesWorkforceDiversityhealth disparitieshealth policyradiation oncologyradiologyunderrepresented minorities

Identifiers

PMID24993534
PMCPMC4332829

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.